Skip to main content
Journal of Translational Medicine logoLink to Journal of Translational Medicine
. 2021 May 21;19:217. doi: 10.1186/s12967-021-02875-6

Publisher Correction to: Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole

Journal of Translational Medicine1
PMCID: PMC8139027  PMID: 34020666

Publisher Correction to: J Transl Med (2021) 19: 50 10.1186/s12967-021-02721-9

During the publication process an error was introduced in the original publication of this article [1].

In Table 1 the value for Concurrent antidepressant use was accidentally changed. In this correction article the incorrect and correct values are published for clarification. The full table is available via the original article. The publisher apologizes to the readers and authors for the inconvenience. The original article has been updated.

Incorrect

Demographics Responders
Concurrent antidepressant use 46,175 (61.3%)*

*p=0.145

Correct

Demographics Responders
Concurrent antidepressant use 46/75 (61.3%)

*p=0.145

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Crosby LD, Kalanidhi S, Bonilla A, Subramanian A, Ballon JS, Bonilla H. Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole. J Transl Med. 2021;19:50. doi: 10.1186/s12967-021-02721-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Translational Medicine are provided here courtesy of BMC

RESOURCES